Skip to content

The effect of methotrexate and cyclosporine on lichenplanopilaris

Clinical trial of comparison of methotrexate versus cyclosporine on disease activity index in patients with lichen planopilaris

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190717044256N1
Enrollment
32
Registered
2019-08-30
Start date
2017-09-23
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lichen planopilaris. Lichen planopilaris

Interventions

Intervention 1: Intervention group: Methotrexate(15mg/week orally,in one day) will be administered in one group(16 patients) for six months. Intervention 2: Intervention group: Cyclosporine( 300mg/day

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Scalp involvement more than 10% Local disease (<10%Involvement) resistant to 3-month topical treatment or 6-months systemic treatment The patients should be stopped all systemic or topical medications at least one month before enrollment to the study

Exclusion criteria

Exclusion criteria: Pregnancy lactation Hb50% or >25% by lower doses of drug(25-50% over 2weeks)

Design outcomes

Primary

MeasureTime frame
Lichen planopilaris activity. Timepoint: Before and after 2,4,6 months after intervention. Method of measurement: Checklist of criteria in lichen planopilaris activity index ; Lichen planopilaris activity index is measured by this formula:LPPAI = (itch + pain + burn ) / 3 + (scalp erythema + perifollicular erythema +perifollicular scale) / 3 + 2.5(pull test) + 1.5(spreading / 2).;Standardized global photography. Timepoint: Before and after intervention. Method of measurement: Based on scoring by two dermatologists.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMinoo Jelvan,MD

Esfahan University of Medical Sciences

Minoo.jelvan@gmail.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 26, 2026